Lipodystrophy clinical trials
The registry lists 163 studies for Lipodystrophy across more than 10 countries. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 118
- Status unknown
- 19
- Recruiting
- 8
- Terminated
- 8
- Withdrawn
- 3
- Active, not recruiting
- 2
Phase
- Phase 2
- 28
- Phase 4
- 26
- Phase 3
- 13
- Phase 1
- 11
- Early Phase 1
- 1
Where
- United States
- 88
- France
- 16
- United Kingdom
- 9
- Canada
- 9
- Brazil
- 8
- Spain
- 8
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (13) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (12) · University of Texas Southwestern Medical Center (7) · Centre Hospitalier Universitaire de la Réunion (5) · Kirby Institute (4) · I.R.A. Istituto Ricerche Applicate S.p.A. (4) · Massachusetts General Hospital (4) · French National Agency for Research on AIDS and Viral Hepatitis (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 163 — search for more.
- Effects of Meal Macronutrients on Postprandial LipidsNot yet recruitingNCT07313787Phase 21 country
- Sexual Quality of Life in Female Patients With Lipodystrophy Syndromes or Turner's Syndrome: a Case-control StudyNot yet recruitingNCT077990121 country
- Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)RecruitingNCT059965361 country
- Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With LipodystrophyRecruitingNCT054190371 country
- MEASuRE: Metreleptin Effectiveness And Safety RegistryRecruitingNCT023256745 countries
- The LD Lync Study - Natural History Study of Lipodystrophy SyndromesRecruitingNCT030872533 countries
- Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin SignalingAvailableNCT04710056
- Registry for Patients With LipodystrophyRecruitingNCT0355342016 countries
- The Skin Barrier in Users of Diabetes DevicesRecruitingNCT068569541 country
- Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"RecruitingNCT06236932Not applicable1 country
- Low Energy Diet and Familial Partial LipodystrophyRecruitingNCT03900286Not applicable1 country
- Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyActive, not recruitingNCT02262832Phase 31 country
- Compassionate Use of Metreleptin in Previously Treated People With Partial LipodystrophyActive, not recruitingNCT02262806Phase 21 country
- Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island SubjectsCompletedNCT06107439Not applicable1 country
- Expanded Access for Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With LipodystrophyNo longer availableNCT00677313
- Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan's Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose)CompletedNCT05789251Not applicable1 country
- Identification of a New Gene Involved in Hereditary LipodystrophyCompletedNCT02056912Not applicable1 country
- Study of the Subdermal Implant "Ultracol"CompletedNCT07617350Not applicable1 country
- Study of the Subdermal Implant "Algeness"CompletedNCT07618468Not applicable1 country
- Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and ObesityCompletedNCT017842891 country
- The Cleveland Cardiometabolic CohortCompletedNCT030591211 country
- Immunogenicity of Metreleptin in Patients With Generalized LipodystrophyCompletedNCT04026178Phase 41 country
- Hemoglobin Level, Coagulopathy Profile and Electrolyte BalanceCompletedNCT046560541 country
- Cholic Acid for Hepatic Steatosis in LipodystrophyCompletedNCT00457639Phase 21 country
- The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.CompletedNCT070906291 country
- Carotid Doppler Peak Velocity Variation in Liposuction Fluid ManagementCompletedNCT05930106Not applicable1 country
- Evaluation of HA Dermal Fillers in the Treatment of Pathological Facial LipoatrophyCompletedNCT05776836Not applicable1 country
- Compassionate Use Protocol for the Treatment of Autoinflammatory SyndromesApproved for marketingNCT017245802 countries
- Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or ScarsCompletedNCT03050749Not applicable1 country
- Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or ScarsCompletedNCT03050723Not applicable1 country
- Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)CompletedNCT02914886Phase 4
- Phase 2 Study of Obeticholic Acid for Lipodystrophy PatientsCompletedNCT02430077Phase 21 country
- Performance and Safety of the Lipo-transfer Cannulas in Patients Underlying Lipofilling TreatmentCompletedNCT060897591 country
- Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's DiseaseCompletedNCT038178401 country
- Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected IndividualsCompletedNCT04904406Phase 41 country
- Trial of Leptin Replacement Therapy in Patients With LipodystrophyCompletedNCT00896298Phase 2/31 country
- A Study to Evaluate the Safety and Efficacy of Revanesse Shape + With Lidocaine Versus Juvederm Voluma With Lidocaine for the Correction of Age-Related Midface Volume Deficit / Lipoatrophy at 6 and 12 Months Post-treatmentCompletedNCT04927052Not applicable1 country
- Intraoperative Fluid Management of Liposuction , Cardiometry Versus Rohrich FormulaCompletedNCT05402982Not applicable1 country
- The Visceral Adiposity Measurement and Observation StudyCompletedNCT053834561 country
- Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's LipodystrophyCompletedNCT05424913Not applicable1 country
- Contribution of Dolutegravir to Obesity and Cardiovascular DiseaseCompletedNCT04340388Phase 41 country
- Safety and Efficacy of Injectable Poly-L-Lactic Acid for Volume Loss in the Temples Using Dual Plane InjectionsStatus unknownNCT05608239Not applicable
- Evaluating the Performance and Safety of the Medical Device Plenhyage® in the Treatment of Dermal Tissue DefectsStatus unknownNCT05239117Not applicable1 country
- Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue DefectsStatus unknownNCT05239130Not applicable1 country
- Evaluating Performance and Safety of the Medical Device Jalucomplex in the Treatment of Facial and Neck Tissue DefectsCompletedNCT05239351Not applicable1 country
- Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin TighteningCompletedNCT00585715Not applicable1 country
- Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue DefectsCompletedNCT05239156Not applicable1 country
- TH9507 Extension Study in Patients With HIV-Associated LipodystrophyCompletedNCT00608023Phase 36 countries
- Morphological and Functional Evaluation of Buttock Lipoatrophy Treatment With MacrolaneCompletedNCT00931268Not applicable1 country
- Growth Hormone Dynamics and Cardiac Steatosis in HIVCompletedNCT038261601 country